Vivos Therapeutics (VVOS)
(Delayed Data from NSDQ)
$2.46 USD
-0.11 (-4.28%)
Updated Apr 25, 2024 03:59 PM ET
After-Market: $2.46 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
VVOS 2.46 -0.11(-4.28%)
Will VVOS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for VVOS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VVOS
Here Is Why Bargain Hunters Would Love Fast-paced Mover Vivos Therapeutics, Inc. (VVOS)
Here's Why Vivos Therapeutics, Inc. (VVOS) Could be Great Choice for a Bottom Fisher
VVOS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Tops Revenue Estimates
Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates
Other News for VVOS
Why Is Laser Photonics (LASE) Stock Up 130% Today?
Medicare to reimburse for Vivos CARE sleep apnea devices
Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today?
Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
Vivos gets approvals to enable Medicare reimbursement for CARE oral devices